Guggenheim Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.3M | Sell |
140,573
-2,718
| -2% | -$224K | 0.09% | 248 |
|
|
2025
Q4 | $12.2M | Sell |
143,291
-50,225
| -26% | -$4.12M | 0.09% | 237 |
|
|
2025
Q3 | $15M | Sell |
193,516
-666
| -0.3% | -$52K | 0.11% | 184 |
|
|
2025
Q2 | $15.2M | Sell |
194,182
-5,877
| -3% | -$438K | 0.12% | 170 |
|
|
2025
Q1 | $14.5M | Sell |
200,059
-15,347
| -7% | -$1.1M | 0.13% | 157 |
|
|
2024
Q4 | $15.9M | Sell |
215,406
-15,358
| -7% | -$1.07M | 0.13% | 153 |
|
|
2024
Q3 | $15.2M | Buy |
230,764
+4,132
| +2% | +$300K | 0.11% | 194 |
|
|
2024
Q2 | $20.9M | Buy |
226,632
+15,417
| +7% | +$1.37M | 0.15% | 130 |
|
|
2024
Q1 | $20.2M | Buy |
211,215
+4,086
| +2% | +$343K | 0.14% | 145 |
|
|
2023
Q4 | $15.8M | Buy |
207,129
+7,139
| +4% | +$497K | 0.12% | 180 |
|
|
2023
Q3 | $13.9M | Sell |
199,990
-34,644
| -15% | -$2.78M | 0.12% | 186 |
|
|
2023
Q2 | $22.1M | Sell |
234,634
-4,207
| -2% | -$366K | 0.17% | 115 |
|
|
2023
Q1 | $19.8M | Buy |
238,841
+3,845
| +2% | +$302K | 0.17% | 124 |
|
|
2022
Q4 | $17.5M | Buy |
234,996
+33,144
| +16% | +$2.55M | 0.15% | 152 |
|
|
2022
Q3 | $16.7M | Buy |
201,852
+19,541
| +11% | +$1.88M | 0.15% | 155 |
|
|
2022
Q2 | $17.3M | Sell |
182,311
-4,668
| -2% | -$483K | 0.14% | 168 |
|
|
2022
Q1 | $22M | Sell |
186,979
-29,131
| -13% | -$3.27M | 0.13% | 177 |
|
|
2021
Q4 | $28M | Buy |
216,110
+42,212
| +24% | +$4.92M | 0.15% | 142 |
|
|
2021
Q3 | $19.7M | Buy |
173,898
+14,602
| +9% | +$1.67M | 0.12% | 181 |
|
|
2021
Q2 | $16.5M | Sell |
159,296
-14,455
| -8% | -$1.36M | 0.1% | 231 |
|
|
2021
Q1 | $14.5M | Buy |
173,751
+8,842
| +5% | +$748K | 0.1% | 251 |
|
|
2020
Q4 | $15M | Sell |
164,909
-2,331
| -1% | -$193K | 0.09% | 211 |
|
|
2020
Q3 | $13.3M | Buy |
167,240
+15,479
| +10% | +$1.21M | 0.1% | 199 |
|
|
2020
Q2 | $10.5M | Sell |
151,761
-10,659
| -7% | -$757K | 0.08% | 261 |
|
|
2020
Q1 | $10.2M | Buy |
162,420
+54,738
| +51% | +$3.95M | 0.1% | 205 |
|
|
2019
Q4 | $8.37M | Sell |
107,682
-59,565
| -36% | -$4.65M | 0.06% | 385 |
|
|
2019
Q3 | $12.3M | Sell |
167,247
-64,929
| -28% | -$4.56M | 0.1% | 243 |
|
|
2019
Q2 | $14.3M | Sell |
232,176
-25,011
| -10% | -$1.51M | 0.12% | 189 |
|
|
2019
Q1 | $16.4M | Sell |
257,187
-58,974
| -19% | -$3.37M | 0.13% | 157 |
|
|
2018
Q4 | $16.1M | Sell |
316,161
-43,011
| -12% | -$2.18M | 0.14% | 145 |
|
|
2018
Q3 | $20.8M | Buy |
359,172
+38,625
| +12% | +$1.89M | 0.14% | 132 |
|
|
2018
Q2 | $15.6M | Sell |
320,547
-1,451,805
| -82% | -$67.8M | 0.1% | 200 |
|
|
2018
Q1 | $82.4M | Sell |
1,772,352
-185,271
| -9% | -$8.05M | 0.2% | 80 |
|
|
2017
Q4 | $73.5M | Buy |
1,957,623
+266,793
| +16% | +$9.79M | 0.17% | 132 |
|
|
2017
Q3 | $61.6M | Buy |
1,690,830
+31,740
| +2% | +$1.21M | 0.14% | 181 |
|
|
2017
Q2 | $65.4M | Sell |
1,659,090
-133,344
| -7% | -$4.87M | 0.17% | 138 |
|
|
2017
Q1 | $56.2M | Buy |
1,792,434
+76,386
| +4% | +$2.39M | 0.15% | 198 |
|
|
2016
Q4 | $53.6M | Buy |
1,716,048
+105,609
| +7% | +$3.42M | 0.15% | 184 |
|
|
2016
Q3 | $64.7M | Sell |
1,610,439
-269,739
| -14% | -$10.2M | 0.2% | 76 |
|
|
2016
Q2 | $62.5M | Buy |
1,880,178
+203,031
| +12% | +$6.95M | 0.2% | 88 |
|
|
2016
Q1 | $49.3M | Sell |
1,677,147
-420,714
| -20% | -$11.6M | 0.16% | 160 |
|
|
2015
Q4 | $55.2M | Sell |
2,097,861
-1,178,001
| -36% | -$30.6M | 0.16% | 148 |
|
|
2015
Q3 | $77.6M | Sell |
3,275,862
-302,778
| -8% | -$7.31M | 0.24% | 45 |
|
|
2015
Q2 | $85M | Buy |
3,578,640
+168,144
| +5% | +$3.79M | 0.21% | 59 |
|
|
2015
Q1 | $81M | Sell |
3,410,496
-1,544,520
| -31% | -$34.7M | 0.19% | 78 |
|
|
2014
Q4 | $105M | Buy |
4,955,016
+1,801,056
| +57% | +$36.2M | 0.26% | 34 |
|
|
2014
Q3 | $53.7M | Sell |
3,153,960
-1,768,686
| -36% | -$27.9M | 0.13% | 185 |
|
|
2014
Q2 | $70.4M | Buy |
4,922,646
+1,707,426
| +53% | +$23.1M | 0.18% | 95 |
|
|
2014
Q1 | $39.7M | Sell |
3,215,220
-97,644
| -3% | -$1.13M | 0.11% | 237 |
|
|
2013
Q4 | $36.3M | Buy |
3,312,864
+1,708,152
| +106% | +$19.3M | 0.11% | 236 |
|
|
2013
Q3 | $18.6M | Buy |
1,604,712
+277,368
| +21% | +$3.24M | 0.07% | 491 |
|
|
2013
Q2 | $14.9M | Buy |
+1,327,344
| New | +$15.7M | 0.06% | 528 |
|
Other funds holding EW
VCM
VPM
Guggenheim Capital's EW Position: Q1 2026 in Review
Guggenheim Capital reduced its Edwards Lifesciences (EW) stake by 1.9% in Q1 2026, selling an estimated $224K and leaving 140,573 shares worth $11.3M. The position accounts for 0.09% of the portfolio, ranked #248.
Guggenheim Capital first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $105M in Q4 2014. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Guggenheim Capital held 140,573 shares of Edwards Lifesciences worth $11.3M as of Q1 2026.
- Guggenheim Capital sold 2,718 Edwards Lifesciences shares in Q1 2026, an estimated $224K.
- Edwards Lifesciences made up 0.09% of Guggenheim Capital's portfolio in Q1 2026, its #248 holding.
- Guggenheim Capital first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Guggenheim Capital's Edwards Lifesciences position peaked at $105M in Q4 2014.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.